{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:09:58Z","timestamp":1781485798559,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1136\/ijgc-2018-000056","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T14:43:09Z","timestamp":1547476989000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study"],"prefix":"10.1016","volume":"29","author":[{"given":"Gitte","family":"\u00d8rtoft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone K","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrid S","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Dueholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2018-000056_bb0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0090-8258(03)00087-8","article-title":"Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy","volume":"89","author":"Straughn","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0360-3016(90)90477-2","article-title":"Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium","volume":"19","author":"Greven","year":"1990","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1136\/ijgc-2018-000056_bb0030","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/IGC.0b013e3182a5e77d","article-title":"Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: the Danish Endometrial Cancer Study","volume":"23","author":"\u00d8rtoft","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000056_bb0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/IGC.0b013e318229264e","article-title":"Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA)","volume":"21","author":"Bertelsen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000056_bb0040","first-page":"419","article-title":"Postoperative external irradiation and prognosis parameters in stage I endometrial carcinoma: clinical and histopathogenic study of 540 patients","volume":"56","author":"Alders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2018-000056_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000056_bb0050","first-page":"1625","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","author":"Kong","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2018-000056_bb0055","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/CLEP.S99479","article-title":"Danish gynecological cancer database","volume":"8","author":"S\u00f8rensen","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1136\/ijgc-2018-000056_bb0065","first-page":"A4864","article-title":"Valid and complete data on endometrial cancer in the Danish Gynaecological Cancer Database","volume":"61","author":"Juhl","year":"2014","journal-title":"Dan Med J"},{"key":"10.1136\/ijgc-2018-000056_bb0070","author":"StataCorp","year":"2009"},{"key":"10.1136\/ijgc-2018-000056_bb0075","article-title":"The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high-risk: a Danish Gynecological Cancer Group Study","author":"Ortoft","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000056_bb0080","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2018-000056_bb0085","first-page":"612","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: a systematic review and meta-analysis","volume":"49","author":"L ZH","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0090","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0095","article-title":"Adjuvant chemotherapy for endometrial cancer after hysterectomy","volume":"10","author":"Johnson","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"15_suppl","key":"10.1136\/ijgc-2018-000056_bb0100","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.5505","article-title":"A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma","volume":"35","author":"Matei","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"10.1136\/ijgc-2018-000056_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0110","article-title":"The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma","author":"Shaikh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"The Astec EN5 writing committee on behalf of the Astec EN 5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2018-000056_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"The writing committee on behalf of the, Astec Study Group","year":"2009","journal-title":"The Lancet"},{"key":"10.1136\/ijgc-2018-000056_bb0125","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1136\/ijgc-2018-000056_bb0130","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2018-000056_bb0135","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2013.48.8023","article-title":"Long-term outcomes after pelvic radiation for early-stage endometrial cancer","volume":"31","author":"Onsrud","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000056_bb0140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"The Lancet"},{"key":"10.1136\/ijgc-2018-000056_bb0145","unstructured":"Clinical Trials Gov . ENGOT-EN2 chemotherapy or observation in stage I-II intermediate or high risk endometrial cancer. NCT01244789. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01244789"}],"updated-by":[{"DOI":"10.1136\/ijgc-2018-000056corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000}}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2018-000056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:24:09Z","timestamp":1753233849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24011046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1048891X24011046"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2018-000056","relation":{"erratum":[{"id-type":"doi","id":"10.1136\/ijgc-2018-000056corr1","asserted-by":"object"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2018-000056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}